Status:

COMPLETED

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

Lead Sponsor:

Amgen

Conditions:

Atopic Dermatitis

Eligibility:

All Genders

18-100 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Eligibility Criteria

Inclusion

  • Age ≥ 18 years with a diagnosis of AD according to the AAD Consensus Criteria (2014) present for at least 12 months
  • History of inadequate response to TCS (Topical Corticosteroid) of medium to higher potency (with or without topical calcineurin inhibitors \[TCI\]).
  • EASI score ≥16
  • vIGA-AD score ≥3
  • ≥10% body surface area (BSA) of AD involvement
  • Worst pruritus numerical rating scale ≥ 4

Exclusion

  • Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
  • Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:
  • Systemic corticosteroids
  • Systemic immunosuppressants
  • Phototherapy
  • Janus kinase inhibitors
  • Treatment with any of the following medications or therapies within 1 week, prior to Day 1:
  • TCS of any potency
  • TCI
  • Topical phosphodiesterase type 4 inhibitors
  • Other topical immunosuppressive agents
  • Combination topical agents including TCS of any potency, TCI, PDE4 inhibitors, or other topical immunosuppressive agents

Key Trial Info

Start Date :

May 31 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 13 2025

Estimated Enrollment :

769 Patients enrolled

Trial Details

Trial ID

NCT05398445

Start Date

May 31 2022

End Date

January 13 2025

Last Update

November 24 2025

Active Locations (202)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 51 (202 locations)

1

Cahaba Dermatology and Skin Health Center

Birmingham, Alabama, United States, 35244

2

Alliance Dermatology and Mohs Center

Phoenix, Arizona, United States, 85032

3

Anaheim Clinical Trials

Anaheim, California, United States, 92801

4

First OC Dermatology

Fountain Valley, California, United States, 92708